Subverted macrophages in the triple-negative breast cancer ecosystem

被引:6
作者
Shang, Linxiao [1 ]
Zhong, Yuting [2 ]
Yao, Yan [2 ]
Liu, Cun [3 ]
Wang, Lu [4 ]
Zhang, Wenfeng [5 ]
Liu, Jingyang [2 ]
Wang, Xue [4 ]
Sun, Changgang [6 ,7 ]
机构
[1] Binzhou Med Univ, Sch Integrated Tradit Chinese & Western Med, Yantai 264000, Peoples R China
[2] Shandong Univ Tradit Chinese Med, Coll Clin Med 1, Jinan 250022, Peoples R China
[3] Weifang Med Univ, Coll Tradit Chinese Med, Weifang 261000, Peoples R China
[4] Shandong Univ Tradit Chinese Med, Coll Tradit Chinese Med, Jinan 250022, Peoples R China
[5] Macau Univ Sci & Technol, Sch Tradit Chinese Med, Macau 999078, Peoples R China
[6] Weifang Tradit Chinese Hosp, Dept Oncol, Weifang 261000, Peoples R China
[7] Weifang Tradit Chinese Hosp, Dept Oncol, Weifang, Peoples R China
基金
中国国家自然科学基金;
关键词
Tumor -associated macrophage; Triple-negative breast cancer; Target; Immunosuppression; Subvert; TUMOR-ASSOCIATED MACROPHAGES; MONOCLONAL-ANTIBODY THERAPY; CHECKPOINT BLOCKADE; CELLS; MICROENVIRONMENT; POLARIZATION; RESISTANCE; RECEPTOR; NANOPARTICLES; PHAGOCYTOSIS;
D O I
10.1016/j.biopha.2023.115414
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Tumor-associated macrophages (TAMs) are the most critical effector cells of innate immunity and the most abundant tumor-infiltrating immune cells. They play a key role in the clearance of apoptotic bodies, regulation of inflammation, and tissue repair to maintain homeostasis in vivo. With the progression of triple-negative breast cancer(TNBC), TAMs are "subverted" from tumor-promoting immune cells to tumor-promoting immune suppressor cells, which play a significant role in tumor development and are considered potential targets for cancer therapy. Here, we explored how macrophages, as the most important part of the TNBC ecosystem, are "subverted" to drive cancer evolution and the uniqueness of TAMs in TNBC progression and metastasis. Similarly, we discuss the rationale and available evidence for TAMs as potential targets for TNBC therapy.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Theranostics for Triple-Negative Breast Cancer
    Choi, Hyeryeon
    Kim, Kwangsoon
    DIAGNOSTICS, 2023, 13 (02)
  • [22] Immunotherapy in Triple-Negative Breast Cancer
    Emens, Leisha A.
    CANCER JOURNAL, 2021, 27 (01) : 59 - 66
  • [23] Advanced Triple-Negative Breast Cancer
    Patel, Grisma
    Prince, Alison
    Harries, Mark
    SEMINARS IN ONCOLOGY NURSING, 2024, 40 (01)
  • [24] Metastatic Triple-Negative Breast Cancer
    Zhang, Xiaojie
    Yeung, Kay T.
    CURRENT BREAST CANCER REPORTS, 2023, 15 (03) : 288 - 297
  • [25] Metastatic Triple-Negative Breast Cancer
    Xiaojie Zhang
    Kay T. Yeung
    Current Breast Cancer Reports, 2023, 15 : 288 - 297
  • [26] MicroRNAs in triple-negative breast cancer
    Koleckova, M.
    Janikova, M.
    Kolar, Z.
    NEOPLASMA, 2018, 65 (01) : 1 - 13
  • [27] UCHL1 promotes cancer stemness in triple-negative breast cancer
    Tian, Chuntao
    Liu, Ying
    Liu, Yixiong
    Hu, Peizhen
    Xie, Shenglong
    Guo, Yu
    Wang, Hui
    Zhang, Zhiyong
    Du, Liuyang
    Lei, Binhua
    Wang, Yingping
    Xue, Lingfei
    Zhang, Dong
    Su, Jing
    Zhang, Xiaotong
    Zhang, Ruiwen
    Chen, Jiaohong
    Zhang, Xiangqian
    Chen, Ligang
    Li, Mingyang
    Jia, Qingge
    Song, Junyang
    Liu, Jin
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 240
  • [28] Tumor-Associated Macrophages: Key Players in Triple-Negative Breast Cancer
    Qiu, Xia
    Zhao, Tianjiao
    Luo, Ran
    Qiu, Ran
    Li, Zhaoming
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [29] HMGA2 Supports Cancer Hallmarks in Triple-Negative Breast Cancer
    Mansoori, Behzad
    Terp, Mikkel Green
    Mohammadi, Ali
    Pedersen, Christina Bog
    Ditzel, Henrik Jorn
    Baradaran, Behzad
    Gjerstorff, Morten Frier
    CANCERS, 2021, 13 (20)
  • [30] Functional Proteomic Profiling of Triple-Negative Breast Cancer
    Gromova, Irina
    Espinoza, Jaime A.
    Grauslund, Morten
    Santoni-Rugiu, Eric
    Talman, Maj-Lis Moller
    van Oostrum, Jan
    Moreira, Jose M. A.
    CELLS, 2021, 10 (10)